logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5476.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5476.produswest2
Healthcare needs of older people in humanitarian settings | Collections | MSF Science Portal
Healthcare needs of older people in humanitarian settings

Healthcare needs of older people in humanitarian settings

Globally, the number of older people is rapidly increasing, with those aged 60+ expected to more than double by 2050—yet in humanitarian crises, they remain one of the most neglected groups. Older adults often face higher risks due to chronic illnesses, mobility issues, and limited access to appropriate care, especially in low-resource or emergency settings. Despite these needs, humanitarian responses rarely prioritize them, and data on their health and mortality are often lacking.


This collection reflects MSF’s ongoing examination of its own data and practices to identify pathways toward more age-inclusive services in humanitarian crises. It includes analysis of data from MSF-supported mental health services, inpatient departments, and sexual violence services, and further offers several calls to action and reflections on why older people remain overlooked in humanitarian crises. However, MSF also acknowledges major challenges remain, including inadequate age-inclusive services, data gaps, and the need for more geriatric expertise.


Watch this space for more publications from a Lancet Healthy Longevity series on healthcare rights and needs of older people.


Collection Content

Journal Article
|
Research

Mental health of older adults in humanitarian settings in low- and middle-income countries: a retrospective analysis from Médecins sans Frontières-supported mental health services, 2019–2024

van Boetzelaer E, Keating P, Wasara N, Rodriguez E, Escobio F,  et al.
2025-07-05 • BMJ Global Health
2025-07-05 • BMJ Global Health

BACKGROUND

More complex humanitarian emergencies have a profound impact on a rapidly growing ageing population. There are few data available on the mental healt...

Journal Article
|
Review

Health needs of older people and age-inclusive health care in humanitarian emergencies in low-income and middle-income countries: a systematic review

van Boetzelaer E, Rathod L, Keating P, Pellecchia U, Sharma S,  et al.
2024-12-30 • The Lancet Healthy Longevity
2024-12-30 • The Lancet Healthy Longevity
Journal Article
|
Commentary

Involving older people in the preparedness, response, and recovery phases in humanitarian emergencies: a theoretical framework on ageism, epistemic injustice, and participation

van Boetzelaer E, van de Kamp J, Keating P, Sharma SK, Pellecchia U,  et al.
2024-01-01 • The Lancet Healthy Longevity
2024-01-01 • The Lancet Healthy Longevity
Journal Article
|
Letter

The disproportionate vulnerability of older people in humanitarian emergencies

van Boetzelaer E, Franco OH, Moussally K, Khammash U, Escobio F
2023-10-20 • Lancet
2023-10-20 • Lancet
Journal Article
|
Commentary

Elderly people in humanitarian crises, a forgotten population: A call for action

van Boetzelaer E, Browne JL, Vaid S, Pellecchia U, van de Kamp J,  et al.
2023-07-17 • PLOS Global Public Health
2023-07-17 • PLOS Global Public Health
Journal Blog
|
Perspective

Conflict in eastern Ukraine is a reminder that older people are especially vulnerable in emergencies

Simonyan G
2019-06-04 • BMJ Opinion (blog)
2019-06-04 • BMJ Opinion (blog)
Journal Article
|
Commentary

Ending neglect of older people in the response to humanitarian emergencies

Karunakara U, Stevenson F
2012-12-18 • PLOS Medicine
2012-12-18 • PLOS Medicine

See more collections

MSF logo
Costs, cost-effectiveness, and financing of tuberculosis trea...

Tuberculosis (TB) is the world's deadliest infectious disease, and the leading killer of people with HIV. TB is curable, but it can be difficult to diagnose and tough to treat, especially for increasingly prevalent drug-resistant TB. In 2023, 22,700 people started TB treatment in MSF programs. Understanding the costs and cost-effectiveness associated with TB treatment and innovations, ranging from TB diagnostics and medications to TB care models, can help to plan resource needs and allocate resources effectively. Analyzing financing mechanisms can support developing sustainable funding models for TB control.

This collection spotlights articles by MSF and collaborators to analyze and document the costs of care, particularly diagnostics and medications.

Safe abortion care at MSF
Safe abortion care at MSF

Unsafe abortion is a major cause of maternal death, and the only one that is completely preventable. Yet over 30 million unsafe abortions occur each year, leading to at least 29,000 deaths and millions of serious complications—nearly all in low- and middle-income countries. MSF teams see these tragic consequences first-hand, treating thousands of patients every year with severe, potentially life-threatening effects from unsafe abortion.


To mark International Safe Abortion Awareness Day (28 September 2024), this Collection presents highlights of MSF’s work on safe abortion care (SAC) as a way to reduce maternal death and injury. By re-assessing and reshaping how our projects deliver SAC in fragile and conflict-affected settings, we have been able to significantly expand services in those contexts and across MSF projects globally. In parallel, we also conducted in-depth studies of abortion complications and their contributing factors in fragile settings, where a dearth of evidence limits understanding of women's needs in accessing comprehensive care. These findings are helping to identify gaps in service delivery and inform operational decision-making.

Mini-Lab—MSF's simplified bacteriology laboratory for low-resource settings
Mini-Lab—MSF's simplified bacteriology laboratory for low-res...
Resistance to antibiotics is a growing public health crisis, especially in countries with fragile health systems and in regions at war. One key limitation in most of these settings is a lack of clinical bacteriology laboratory capacity, which leaves medical providers without ways to accurately diagnose patient infections and to tailor antibiotic treatment accordingly. To help fill this critical gap, MSF and partners have developed the Mini-Lab—a small-scale, standalone lab that is easy to transport, set up and operate by staff after only a short training. Its six modules are stocked with everything needed to diagnose common bloodstream and urinary tract infections and to perform antibiotic sensitivity testing using methods adapted to extremely hot climates and remote settings. With Mini-Lab now being rolled out to selected MSF projects, here we highlight the background to its development and some of the research behind the bacteriological tests it incorporates.
View All Collections